Epitope Mapping with Diethylpyrocarbonate Covalent Labeling-Mass Spectrometry

Anal Chem. 2022 Jan 18;94(2):1052-1059. doi: 10.1021/acs.analchem.1c04038. Epub 2021 Dec 21.

Abstract

Antigen-antibody epitope mapping is essential for understanding binding mechanisms and developing new protein therapeutics. In this study, we investigate diethylpyrocarbonate (DEPC) covalent labeling-mass spectrometry as a means of analyzing antigen-antibody interactions using the well-characterized model system of TNFα in complex with three different antibodies. Results show that residues buried in the epitope undergo substantial decreases in labeling, as expected. Interestingly, serine, threonine, and tyrosine residues at the edges of the epitope undergo unexpected increases in labeling. The increased labeling of these weakly nucleophilic residues is caused by the formation of hydrophobic pockets upon antibody binding that presumably increase local DEPC concentrations. Residues that are distant from the epitope generally do not undergo changes in labeling extent; however, some that do change experience variations in their local microenvironment due to side-chain reorganization or stabilization of the TNFα trimer that occurs upon binding. Overall, DEPC labeling of antigen-antibody complexes is found to depend on both changes in solvent exposure and changes to the residue microenvironment.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Diethyl Pyrocarbonate / chemistry
  • Epitope Mapping
  • Mass Spectrometry / methods
  • Threonine*
  • Tyrosine*

Substances

  • Threonine
  • Tyrosine
  • Diethyl Pyrocarbonate